(Andrea to discuss legal/political requirements with GTLs)
Ensembl receives majority funding from the Wellcome Trust (grant number WT108749/Z/15/Z) with additional funding for specific project components from the National Human Genome Research Institute (U41HG007823 and 2U41HG007234), the Biotechnology and Biological Sciences Research Council (BB/N019563/1 and BB/M011615/1), Open Targets, the Wellcome Trust (WT104947/Z/14/Z, WT200990/Z/16/Z, WT201535/Z/16/Z, WT108749/Z/15/A, WT212925/Z/18/Z), ELIXIR: the research infrastructure for life-science data, and the European Molecular Biology Laboratory. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement n° 733161 (MultipleMS). We also receive funding from the 'Save the Tasmanian Devil Program'.
